Major depression is a debilitating psychiatric illness that is typically
associated with low mood and anhedonia. Depression has a heritable component
that has remained difficult to elucidate with current sample sizes due to the
polygenic nature of the disorder. To maximise sample size, we meta-analysed data
on 807,553 individuals (246,363 cases and 561,190 controls) from the three
largest genome-wide association studies of depression. We identified 102
independent variants, 269 genes, and 15 gene-sets associated with depression,
including both genes and gene-pathways associated with synaptic structure and
neurotransmission. An enrichment analysis provided further evidence of the
importance of prefrontal brain regions. In an independent replication sample of
1,306,354 individuals (414,055 cases and 892,299 controls), 87 of the 102
associated variants were significant following multiple testing correction.
These findings advance our understanding of the complex genetic architecture of
depression and provide several future avenues for understanding aetiology and
developing new treatment approaches.
High blood pressure is a highly heritable and modifiable risk factor for cardiovascular disease. We report the largest genetic association study of blood pressure traits (systolic, diastolic, pulse pressure) to date in over one million people of European ancestry. We identify 535 novel blood pressure loci that not only offer new biological insights into blood pressure regulation but also reveal shared genetic architecture between blood pressure and lifestyle exposures. Our findings identify new biological pathways for blood pressure regulation with potential for improved cardiovascular disease prevention in the future.
A genome-wide association study of educational attainment was conducted in a discovery sample of 101,069 individuals and a replication sample of 25,490. Three independent SNPs are genome-wide significant (rs9320913, rs11584700, rs4851266), and all three replicate. Estimated effects sizes are small (R2 ≈ 0.02%), approximately 1 month of schooling per allele. A linear polygenic score from all measured SNPs accounts for ≈ 2% of the variance in both educational attainment and cognitive function. Genes in the region of the loci have previously been associated with health, cognitive, and central nervous system phenotypes, and bioinformatics analyses suggest the involvement of the anterior caudate nucleus. These findings provide promising candidate SNPs for follow-up work, and our effect size estimates can anchor power analyses in social-science genetics.
Genetic correlations estimated from GWAS reveal pervasive pleiotropy across a wide variety of phenotypes. We introduce genomic structural equation modeling (Genomic SEM), a multivariate method for analyzing the joint genetic architecture of complex traits. Genomic SEM synthesizes genetic correlations and SNP-heritabilities inferred from GWAS summary statistics of individual traits from samples with varying and unknown degrees of overlap. Genomic SEM can be used to model multivariate genetic associations among phenotypes, identify variants with effects on general dimensions of cross-trait liability, calculate more predictive polygenic scores, and identify loci that cause divergence between traits. We demonstrate several applications of Genomic SEM, including a joint analysis of summary statistics from five psychiatric traits. We identify 27 independent SNPs not previously identified in the contributing univariate GWASs. Polygenic scores from Genomic SEM consistently outperform those from univariate GWAS. Genomic SEM is flexible, open ended, and allows for continuous innovation in multivariate genetic analysis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.